FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000046329> ?p ?o ?g. }

• W3000046329 endingPage "788" @default.
• W3000046329 startingPage "778" @default.
• W3000046329 abstract "The mechanism of resistance development to anti-VEGF therapy in ovarian cancer is unclear. We focused on the changes in tumour immunity post anti-VEGF therapy.The frequencies of immune cell populations and hypoxic conditions in the resistant murine tumours and clinical samples were examined. The expression profiles of both the proteins and genes in the resistant tumours were analysed. The impact of granulocyte-monocyte colony-stimulating factor (GM-CSF) expression on myeloid-derived suppressor cell (MDSC) function in the resistant tumours was evaluated.We found a marked increase and reduction in the number of Gr-1 + MDSCs and CD8 + lymphocytes in the resistant tumour, and the MDSCs preferentially infiltrated the hypoxic region. Protein array analysis showed upregulation of GM-CSF post anti-VEGF therapy. GM-CSF promoted migration and differentiation of MDSCs, which inhibited the CD8 + lymphocyte proliferation. Anti-GM-CSF therapy improved the anti-VEGF therapy efficacy, which reduced the infiltrating MDSCs and increased CD8 + lymphocytes. In immunohistochemical analysis of clinical samples, GM-CSF expression and MDSC infiltration was enhanced in the bevacizumab-resistant case.The anti-VEGF therapy induces tumour hypoxia and GM-CSF expression, which recruits MDSCs and inhibits tumour immunity. Targeting the GM-CSF could help overcome the anti-VEGF therapy resistance in ovarian cancers." @default.
• W3000046329 created "2020-01-23" @default.
• W3000046329 creator A5006506867 @default.
• W3000046329 creator A5011585763 @default.
• W3000046329 creator A5022396882 @default.
• W3000046329 creator A5023191265 @default.
• W3000046329 creator A5028226663 @default.
• W3000046329 creator A5028817103 @default.
• W3000046329 creator A5036589972 @default.
• W3000046329 creator A5040013839 @default.
• W3000046329 creator A5051800836 @default.
• W3000046329 creator A5076072821 @default.
• W3000046329 creator A5082910812 @default.
• W3000046329 creator A5087677239 @default.
• W3000046329 creator A5088883992 @default.
• W3000046329 date "2020-01-14" @default.
• W3000046329 modified "2023-10-14" @default.
• W3000046329 title "Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment" @default.
• W3000046329 cites W1793338775 @default.
• W3000046329 cites W1882449923 @default.
• W3000046329 cites W1966996293 @default.
• W3000046329 cites W1990061395 @default.
• W3000046329 cites W1994024307 @default.
• W3000046329 cites W1995232616 @default.
• W3000046329 cites W2004150448 @default.
• W3000046329 cites W2075711878 @default.
• W3000046329 cites W2090672759 @default.
• W3000046329 cites W2095868502 @default.
• W3000046329 cites W2097177355 @default.
• W3000046329 cites W2097432512 @default.
• W3000046329 cites W2103383530 @default.
• W3000046329 cites W2117692326 @default.
• W3000046329 cites W2122403898 @default.
• W3000046329 cites W2123696077 @default.
• W3000046329 cites W2124336639 @default.
• W3000046329 cites W2129176863 @default.
• W3000046329 cites W2131593373 @default.
• W3000046329 cites W2136313650 @default.
• W3000046329 cites W2139877124 @default.
• W3000046329 cites W2142240220 @default.
• W3000046329 cites W2144718958 @default.
• W3000046329 cites W2147622445 @default.
• W3000046329 cites W2151174630 @default.
• W3000046329 cites W2157795344 @default.
• W3000046329 cites W2161717621 @default.
• W3000046329 cites W2217355440 @default.
• W3000046329 cites W2275872217 @default.
• W3000046329 cites W2326749252 @default.
• W3000046329 cites W2341196906 @default.
• W3000046329 cites W2397703541 @default.
• W3000046329 cites W2406005292 @default.
• W3000046329 cites W2464604109 @default.
• W3000046329 cites W2465309696 @default.
• W3000046329 cites W2556561046 @default.
• W3000046329 cites W2583998975 @default.
• W3000046329 cites W2588812529 @default.
• W3000046329 cites W2619442803 @default.
• W3000046329 cites W2772815803 @default.
• W3000046329 cites W2773746576 @default.
• W3000046329 cites W2802016913 @default.
• W3000046329 cites W3112156481 @default.
• W3000046329 cites W4294107304 @default.
• W3000046329 doi "https://doi.org/10.1038/s41416-019-0725-x" @default.
• W3000046329 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7078258" @default.
• W3000046329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31932754" @default.
• W3000046329 hasPublicationYear "2020" @default.
• W3000046329 type Work @default.
• W3000046329 sameAs 3000046329 @default.
• W3000046329 citedByCount "57" @default.
• W3000046329 countsByYear W30000463292020 @default.
• W3000046329 countsByYear W30000463292021 @default.
• W3000046329 countsByYear W30000463292022 @default.
• W3000046329 countsByYear W30000463292023 @default.
• W3000046329 crossrefType "journal-article" @default.
• W3000046329 hasAuthorship W3000046329A5006506867 @default.
• W3000046329 hasAuthorship W3000046329A5011585763 @default.
• W3000046329 hasAuthorship W3000046329A5022396882 @default.
• W3000046329 hasAuthorship W3000046329A5023191265 @default.
• W3000046329 hasAuthorship W3000046329A5028226663 @default.
• W3000046329 hasAuthorship W3000046329A5028817103 @default.
• W3000046329 hasAuthorship W3000046329A5036589972 @default.
• W3000046329 hasAuthorship W3000046329A5040013839 @default.
• W3000046329 hasAuthorship W3000046329A5051800836 @default.
• W3000046329 hasAuthorship W3000046329A5076072821 @default.
• W3000046329 hasAuthorship W3000046329A5082910812 @default.
• W3000046329 hasAuthorship W3000046329A5087677239 @default.
• W3000046329 hasAuthorship W3000046329A5088883992 @default.
• W3000046329 hasBestOaLocation W30000463291 @default.
• W3000046329 hasConcept C121608353 @default.
• W3000046329 hasConcept C126322002 @default.
• W3000046329 hasConcept C167672396 @default.
• W3000046329 hasConcept C179185449 @default.
• W3000046329 hasConcept C203014093 @default.
• W3000046329 hasConcept C2779282312 @default.
• W3000046329 hasConcept C2780394083 @default.
• W3000046329 hasConcept C2780427987 @default.
• W3000046329 hasConcept C502942594 @default.
• W3000046329 hasConcept C55721878 @default.

• next